Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
National HealthCare Corporation's quarterly P/E stands at 12.2x, up 5.5% year-over-year. EV/EBITDA has compressed 31.6% YoY to 11.4x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 21.32 | 12.15 | 17.60 | 11.21 | 68.95 | 11.52 | 15.66 | 13.98 | 12.63 | 23.52 | 14.58 | 19.10 | 36.28 |
| — | +5.5% | +12.4% | -19.8% | +446.1% | -51.0% | +7.4% | -26.8% | -65.2% | — | -88.3% | +7.7% | +117.9% | |
| P/S Ratio | 1.73 | 1.24 | 1.11 | 0.97 | 1.14 | 1.45 | 1.45 | 1.23 | 1.19 | 0.85 | 0.84 | 0.83 | 0.87 |
| — | -14.1% | -23.1% | -21.6% | -4.1% | +70.4% | +72.7% | +49.1% | +37.4% | -5.9% | -16.1% | -18.3% | -11.5% | |
| P/B Ratio | 2.38 | 1.80 | 1.63 | 1.43 | 1.71 | 2.00 | 1.78 | 1.58 | 1.57 | 1.10 | 1.07 | 1.01 | 1.04 |
| — | -9.9% | -8.5% | -9.3% | +9.0% | +80.7% | +66.5% | +56.1% | +51.0% | -0.5% | -10.9% | -15.0% | -9.8% | |
| P/FCF | 17.07 | 8.42 | 7.93 | 10.91 | 90.92 | 49.13 | 9.84 | 99.25 | 20.89 | 9.50 | 7.14 | 30.89 | 36.28 |
| — | -82.9% | -19.4% | -89.0% | +335.3% | +417.0% | +37.9% | +221.3% | -42.4% | — | -52.1% | — | -73.7% | |
| EV / EBITDA | 15.14 | 11.44 | 9.59 | 9.33 | 12.00 | 16.71 | 12.79 | 13.90 | 11.11 | 10.60 | 10.16 | 12.00 | 12.56 |
| — | -31.6% | -25.0% | -32.9% | +7.9% | +57.7% | +25.8% | +15.8% | -11.5% | -43.1% | -48.9% | -3.1% | -12.5% | |
| EV / EBIT | 20.44 | 8.51 | 12.67 | 8.50 | 54.25 | 8.85 | 11.13 | 10.19 | 9.65 | 17.40 | 10.91 | 15.22 | 32.59 |
| — | -3.9% | +13.8% | -16.6% | +462.1% | -49.1% | +2.0% | -33.1% | -70.4% | — | -86.2% | +6.1% | +149.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
National HealthCare Corporation's operating margin was 7.9% in Q3 2025, down 1.2 pp QoQ and up 1.8 pp YoY. Gross margin expanded 4.8% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.3% | 39.1% | 39.6% | 39.0% | 36.6% | 37.3% | 38.2% | 38.4% | 38.0% | 36.7% | 38.0% | 37.7% | 36.6% |
| — | +4.8% | +3.7% | +1.5% | -3.8% | +1.6% | +0.5% | +1.7% | +3.8% | +1.7% | +7.1% | +3.7% | -1.7% | |
| Operating Margin | 8.7% | 7.9% | 9.1% | 8.2% | 7.2% | 6.2% | 7.7% | 5.3% | 6.7% | 4.5% | 4.9% | 3.7% | 3.4% |
| — | +28.3% | +17.6% | +56.5% | +7.6% | +37.0% | +56.3% | +41.6% | +95.1% | +199.9% | +194.6% | -29.9% | +0.6% | |
| Net Margin | 8.2% | 10.3% | 6.3% | 8.6% | 1.6% | 12.6% | 9.2% | 8.8% | 9.4% | 3.6% | 5.8% | 4.3% | 2.4% |
| — | -18.5% | -31.4% | -2.3% | -82.6% | +249.3% | +60.0% | +102.8% | +292.3% | +501.5% | +387.6% | -23.8% | -59.1% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 3.8% | 2.3% | 3.2% | 0.6% | 4.4% | 2.9% | 2.9% | 3.2% | 1.2% | 1.8% | 1.3% | 0.7% |
| — | -14.9% | -18.5% | +13.3% | -80.5% | +277.7% | +55.4% | +113.9% | +337.4% | +530.2% | +422.0% | -20.8% | -58.6% | |
| ROA | — | 2.5% | 1.5% | 2.1% | 0.4% | 2.9% | 2.0% | 2.0% | 2.2% | 0.8% | 1.3% | 0.9% | 0.5% |
| — | -15.1% | -24.5% | +5.2% | -82.0% | +263.7% | +57.9% | +116.0% | +343.4% | +541.6% | +440.5% | -16.8% | -55.9% | |
| ROIC | 8.4% | 2.1% | 2.3% | 2.1% | 1.8% | 1.6% | 1.9% | 1.3% | 1.7% | 1.1% | 1.1% | 0.8% | 0.7% |
| — | +36.4% | +24.1% | +59.4% | +4.5% | +44.2% | +66.4% | +63.1% | +138.5% | +244.8% | +227.5% | -26.4% | -0.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
National HealthCare Corporation's Debt/EBITDA ratio is 3.1x, down from 3.8x last quarter — at a moderate level that warrants monitoring. Debt/Equity has declined for 5 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.12 | 0.17 | 0.20 | 0.22 | 0.23 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 |
| — | -48.4% | +101.3% | +117.5% | +113.0% | +104.9% | -32.2% | -30.8% | -28.5% | -24.5% | -26.8% | -23.6% | -21.8% | |
| Debt / EBITDA | 0.50 | 3.08 | 3.83 | 4.86 | 5.65 | 7.31 | 2.49 | 3.27 | 2.93 | 4.38 | 4.55 | 5.87 | 6.45 |
| — | -57.8% | +53.8% | +48.6% | +93.0% | +66.7% | -45.3% | -44.2% | -54.6% | -52.9% | -56.5% | -11.9% | -25.3% | |
| Current Ratio | — | 1.75 | 1.72 | 1.90 | 1.81 | 1.80 | 2.06 | 2.02 | 1.89 | 1.87 | 1.86 | 1.84 | 1.79 |
| — | -2.8% | -16.5% | -5.9% | -4.6% | -3.8% | +10.7% | +9.7% | +5.9% | +14.0% | +5.9% | +4.0% | +10.3% | |
| Quick Ratio | — | 1.72 | 1.69 | 1.87 | 1.77 | 1.77 | 2.03 | 1.99 | 1.86 | 1.83 | 1.83 | 1.81 | 1.75 |
| — | -2.6% | -16.7% | -6.1% | -4.9% | -3.7% | +11.2% | +10.2% | +6.1% | +14.2% | +5.9% | +4.2% | +10.3% | |
| Interest Coverage | — | 20.86 | — | 14.61 | 11.32 | 12.08 | — | 339.76 | 359.29 | 169.16 | 150.29 | 102.16 | 80.80 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonNational HealthCare Corporation's current P/E is 21.3x. The average P/E over the last 4 quarters is 27.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
National HealthCare Corporation's current operating margin is 8.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking National HealthCare Corporation's business trajectory between earnings reports.